Hurricane Maria Continues to Wreak Havoc on the Medical Industry

Though it has been nearly four months since Hurricane Maria made landfall in Puerto Rico, the effects continue to devastate the medical industry both on the island and the mainland. The power grid on the island remains mostly inoperable, leaving Puerto Rico’s many medical equipment manufacturing plants unable to operate.

The United States Food and Drug Administration (FDA) has confirmed that the U.S. territory of Puerto Rico typically produces about $40 billion worth of pharmaceuticals each year. This amounts to more pharmaceutical production than any one of the 50 states, any other U.S. territory, or any single foreign country. Unfortunately, these productive manufacturing facilities have mostly shut down since Hurricane Maria hit land nearly four months ago, and the plants that are in operation continue to rely on generators.

Three of the affected manufacturing plants are home to Baxter, one of the most significant suppliers of IV bags. All three of Baxter’s plants on the island were forced to stall manufacturing. While two stations are now up and running on generators, the other remains closed.

According to the New York Times, about 10% of the drugs that Americans consume every day are made in Puerto Rico. While the island continues to recover from the devastating hurricane, medical professionals on the mainland should expect low supply, back orders, and price increases.

Unfortunately, these drug shortages could affect Accutome by Keeler and its customers. Ophthalmology offices should be aware of this backup and prepare accordingly. These professionals should expect Accutome and other providers to be out of certain products like morphine, IV solutions, mesh, surgical scalpels, and more. While the provider works hard to secure these products for customers.

The FDA is working with the manufacturers in Puerto Rico to get production back on track. The agency is currently monitoring a total of 90 products in hopes of stopping shortages before they become critical. The administration is also working with Puerto Rico to get manufacturing back on track.

“We continue to work closely with federal and Puerto Rican authorities to address the needs of manufacturers on the island for power and other resources. … Mitigating medical product shortages will require a sustained effort by the industry, the agency, and other partners as we work with manufacturers to return to production levels that adequately meet the needs of patients,” FDA Commissioner Scott Gottlieb, MD, said in a statement.

Thanks to generous tax incentives, Puerto Rico is home to many big-name manufacturers such as Johnson & Johnson, Pfizer, and Abbott Medical Optics. However, because only about half of these manufacturers are producing right now, medical professionals across the United States are destined to feel the shortage.

Since 2014, the FDA has been monitoring Puerto Rico for potential drug shortages. But Hurricane Maria turned a potential problem into a significant and immediate emergency. This shortage has made it difficult for cancer patients to receive proper care because Baxter makes the saline bags used for treatments. Furthermore, care of premature babies has been placed in jeopardy due to the shortage.

Accutome by Keeler is in its fourth decade of operation and will not allow this hurricane to end its reputation as a leader in the ophthalmic industry. With superior customer service, quality, and innovation, the company will continue to serve its customers through this crisis. Customers should feel free to contact their representatives with any questions they may have.

Accutome by Keeler stands with the people of Puerto Rico, its customers, and its commitment to service. While Hurricane Maria may have disrupted supplies, customers will not see a disruption in the service they have come to expect.

Read more at accutome.com

Follow us on social media for the latest updates in B2B!

Image

Latest

Revenue Cycle
Transformation Without Disruption: How Access Healthcare Is Rewiring the Revenue Cycle with Agentic AI
September 17, 2025

Hospitals are juggling shrinking margins and rising costs while denial volumes remain stubbornly high. In the revenue cycle alone, hundreds of billions are lost annually to preventable errors and inefficiencies—in fact, Access Healthcare CEO Shaji Ravi cites more than $250 billion wasted each year. Meanwhile, payers have accelerated their use of AI to adjudicate…

Read More
leading with intention
Making Meaning Out of Life’s Pause: Billie Whitehouse on Finding Strength, Setting Boundaries, and Leading With Intention
September 17, 2025

In June, Forbes profiled Billie Whitehouse, CEO and Creative Director of Wearable X, as she broke her silence about leading through a devastating health crisis. Diagnosed with stage 4 colon cancer at 27 while 22 weeks pregnant, Whitehouse underwent emergency surgery that ensured her survival, but came with the profound heartbreak of losing her…

Read More
Critical Care
Transforming the ICU Through Technology: Advances in Critical Care Telehealth Delivering Gold-Standard Care Anywhere
September 17, 2025

Critical care in the United States faces a mounting crisis. With a shortage of board-certified intensivists and younger, less experienced nurses filling ICUs, hospitals often struggle to provide timely, gold-standard care. Studies show that hospitals with board-certified intensivists in their ICUs see a 30% reduction in patient mortality, yet thousands of facilities still lack…

Read More
How to Scale Events Without Losing the Wow Factor
How to Scale Events Without Losing the Wow Factor
September 17, 2025

In this episode of Secured, host Mike Monsive, CEO of ASAP Security, reconnects with Idan Koren, CMO of Verkada, for a conversation about what it really takes to scale events without losing their impact. Idan shares how his team manages nearly 500 events a year—ranging from intimate gatherings to Verkada One, the company’s flagship…

Read More